GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

ReNerve RNV.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.08

-2.50%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

ReNerve — daily ASX:RNV

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View ReNerve on TradingView ↗
Market value
A$11.1m
Last close × shares
Volume
87.8k
Shares, 9 Nov 2026

About ReNerve

Its shares trade on ASX under the ticker RNV.AX. It has been listed since 26 November 2024. In the fiscal year to 30 June 2026, it reported revenue of A$510,357 and a net loss of A$5.6m. At that date it held total assets of A$4.5m and shareholders' equity of A$3.2m.

ReNerve Ltd is a AU-based company operating in Health Care Equipment & Supplies industry. ReNerve Limited is an Australia-based medical device company developing tissue-based products for peripheral nerve repair and replacement and other related soft tissue surgical procedures. The company is focused on developing products that accelerate tissue regeneration while preventing scarring and negative inflammatory responses. Its products include NervAlign Nerve Cuff, NervAlign Nerve Graft and NervAlign Bionic Nerve. NervAlign Nerve Cuff is a soft, compatible protective wrap used to protect repaired injured nerves. The product is being developed for the surgical repair of transected (cut) and damaged nerves. NervAlign nerve grafts offers surgeons the ability to repair damaged nerves (neurotmesis) without the need to harvest the sural nerve from the patient. The company is developing, NervAlign Bionic Nerve, a combination polymer technology and its nerve graft to produce a replacement nerve that contains shaped ionic polymers which would enable the stimulation of the distal end of a nerve injury.

Figures and description from our data supplier, not checked against the company's own report.

More about ReNerve →

Latest on ReNerve

Our reporting

We have not reported on ReNerve yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is ReNerve's ticker?

ReNerve trades as RNV.AX on ASX, under ISIN AU0000358616.

What was ReNerve's last closing price?

0.08 on 9 Nov 2026. The figure is in AUD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.